• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. May 2005; 64(5): 669–681.
Published online Oct 7, 2004. doi:  10.1136/ard.2004.028886
PMCID: PMC1755499

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)


Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).

Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 European countries. Each participant contributed up to 10 propositions describing key clinical aspects of hip OA management. Ten final recommendations were agreed using a Delphi consensus approach. Medline, Embase, CINAHL, Cochrane Library, and HTA reports were searched systematically to obtain research evidence for each proposition. Where possible, outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. Effect size, rate ratio, number needed to treat, and incremental cost effectiveness ratio were calculated. The quality of evidence was categorised according to the evidence hierarchy. The strength of recommendation was assessed using the traditional A–D grading scale and a visual analogue scale.

Results: Ten key treatment propositions were generated through three Delphi rounds. They included 21 interventions, such as paracetamol, NSAIDs, symptomatic slow acting disease modifying drugs, opioids, intra-articular steroids, non-pharmacological treatment, total hip replacement, osteotomy, and two general propositions. 461 studies were identified from the literature search for the proposed interventions of efficacy, side effects, and cost effectiveness. Research evidence supported 15 interventions in the treatment of hip OA. Evidence specific for the hip was strikingly lacking. Strength of recommendation varied according to category of research evidence and expert opinion.

Conclusion: Ten key recommendations for the treatment of hip OA were developed based on research evidence and expert consensus. The effectiveness and cost effectiveness of these recommendations were evaluated and the strength of recommendation was scored.

Full Text

The Full Text of this article is available as a PDF (165K).

Supplementary Material

[Web-only appendices]

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1–28. [PubMed]
  • Ingvarsson T, Hägglund G, Lohmander LS. Prevalence of hip osteoarthritis in Iceland. Ann Rheum Dis. 1999 Apr;58(4):201–207. [PMC free article] [PubMed]
  • Lanyon P, Muir K, Doherty S, Doherty M. Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. BMJ. 2000 Nov 11;321(7270):1179–1183. [PMC free article] [PubMed]
  • Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998 May;41(5):778–799. [PubMed]
  • Tepper S, Hochberg MC. Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I). Am J Epidemiol. 1993 May 15;137(10):1081–1088. [PubMed]
  • Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003 Dec;62(12):1145–1155. [PMC free article] [PubMed]
  • Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000 Dec;59(12):936–944. [PMC free article] [PubMed]
  • Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999 Feb 27;318(7183):593–596. [PMC free article] [PubMed]
  • Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med. 1991 Nov;10(11):1665–1677. [PubMed]
  • Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995 Feb 18;310(6977):452–454. [PMC free article] [PubMed]
  • Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998 Nov 7;317(7168):1309–1312. [PMC free article] [PubMed]
  • Maistrelli GL, Gerundini M, Fusco U, Bombelli R, Bombelli M, Avai A. Valgus-extension osteotomy for osteoarthritis of the hip. Indications and long-term results. J Bone Joint Surg Br. 1990 Jul;72(4):653–657. [PubMed]
  • Ohashi H, Hirohashi K, Yamano Y. Factors influencing the outcome of Chiari pelvic osteotomy: a long-term follow-up. J Bone Joint Surg Br. 2000 May;82(4):517–525. [PubMed]
  • Birrell Fraser, Afzal Cara, Nahit Elizabeth, Lunt Mark, Macfarlane Gary J, Cooper Cyrus, Croft Peter R, Hosie Gillian, Silman Alan J. Predictors of hip joint replacement in new attenders in primary care with hip pain. Br J Gen Pract. 2003 Jan;53(486):26–30. [PMC free article] [PubMed]
  • Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E. Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol. 1999 Apr;26(4):855–861. [PubMed]
  • Maillefert JF, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazières B, Vignon E, Dougados M. Relevant change in radiological progression in patients with hip osteoarthritis. I. Determination using predictive validity for total hip arthroplasty. Rheumatology (Oxford) 2002 Feb;41(2):142–147. [PubMed]
  • Maillefert Jean Francis, Gueguen Alice, Nguyen Minh, Berdah Laurent, Lequesne Michel, Mazieres Bernard, Vignon Eric, Dougados Maxime. A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol. 2002 Feb;29(2):347–352. [PubMed]
  • Nilsdotter AK, Aurell Y, Siösteen AK, Lohmander LS, Roos HP. Radiographic stage of osteoarthritis or sex of the patient does not predict one year outcome after total hip arthroplasty. Ann Rheum Dis. 2001 Mar;60(3):228–232. [PMC free article] [PubMed]
  • Vinciguerra C, Gueguen A, Revel M, Heuleu JN, Amor B, Dougados M. Predictors of the need for total hip replacement in patients with osteoarthritis of the hip. Rev Rhum Engl Ed. 1995 Oct;62(9):563–570. [PubMed]
  • Mancuso Carol A, Sculco Thomas P, Salvati Eduardo A. Patients with poor preoperative functional status have high expectations of total hip arthroplasty. J Arthroplasty. 2003 Oct;18(7):872–878. [PubMed]
  • Haddad FS, Garbuz DS, Chambers GK, Jagpal TJ, Masri BA, Duncan CP. The expectations of patients undergoing revision hip arthroplasty. J Arthroplasty. 2001 Jan;16(1):87–91. [PubMed]
  • Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment. Arthritis Care Res. 1996 Aug;9(4):292–301. [PubMed]
  • Giraudet-Le Quintrec Janine-Sophie, Coste Joël, Vastel Laurent, Pacault Véronique, Jeanne Luc, Lamas Jean-Paul, Kerboull Luc, Fougeray Martine, Conseiller Christian, Kahan André, et al. Positive effect of patient education for hip surgery: a randomized trial. Clin Orthop Relat Res. 2003 Sep;(414):112–120. [PubMed]
  • Fransen Marlene, McConnell Sara, Bell Mary. Therapeutic exercise for people with osteoarthritis of the hip or knee. A systematic review. J Rheumatol. 2002 Aug;29(8):1737–1745. [PubMed]
  • Fransen M, McConnell S, Bell M. Exercise for osteoarthritis of the hip or knee. Cochrane Database Syst Rev. 2003;(3):CD004286–CD004286. [PubMed]
  • Puett DW, Griffin MR. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med. 1994 Jul 15;121(2):133–140. [PubMed]
  • van Baar ME, Assendelft WJ, Dekker J, Oostendorp RA, Bijlsma JW. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum. 1999 Jul;42(7):1361–1369. [PubMed]
  • Lievense AM, Bierma-Zeinstra SMA, Verhagen AP, van Baar ME, Verhaar JAN, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford) 2002 Oct;41(10):1155–1162. [PubMed]
  • Towheed TE, Judd MJ, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2003;(2):CD004257–CD004257. [PubMed]
  • Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis. 2004 Aug;63(8):901–907. [PMC free article] [PubMed]
  • García Rodríguez LA, Hernández-Díaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. 2001 Sep;12(5):570–576. [PubMed]
  • Rahme Elham, Pettitt Dan, LeLorier Jacques. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum. 2002 Nov;46(11):3046–3054. [PubMed]
  • Lewis SC, Langman MJS, Laporte Joan-Ramon, Matthews John N S, Rawlins Michael D, Wiholm Bengt-Erik. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002 Sep;54(3):320–326. [PMC free article] [PubMed]
  • Jerussi TP, Caubet JF, McCray JE, Handley DA. Clinical endoscopic evaluation of the gastroduodenal tolerance to (R)- ketoprofen, (R)- flurbiprofen, racemic ketoprofen, and paracetamol: a randomized, single-blind, placebo-controlled trial. J Clin Pharmacol. 1998 Feb;38(2 Suppl):19S–24S. [PubMed]
  • Lanza FL, Codispoti JR, Nelson EB. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen. Am J Gastroenterol. 1998 Jul;93(7):1051–1054. [PubMed]
  • Müller P, Simon B, Weise D, Dammann HG. Endoskopische Untersuchungen zur Magenverträglichkeit einer mehrtägigen Gabe von Paracetamol und Acetylsalicylsäure. Eine Plazebo-kontrollierte Doppelblindstudie an gesunden Probanden. Arzneimittelforschung. 1990 Mar;40(3):316–318. [PubMed]
  • Kashem A, Endoh M, Yamauchi F, Yano N, Nomoto Y, Sakai H, Pronai L, Tanaka M, Nakazawa H. Superoxide dismutase activity in human glomerulonephritis. Am J Kidney Dis. 1996 Jul;28(1):14–22. [PubMed]
  • Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA. 2001 Jul 18;286(3):315–321. [PubMed]
  • Zhang WY. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf. 2001;24(15):1127–1142. [PubMed]
  • Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001 Dec 20;345(25):1801–1808. [PubMed]
  • Kamath Celia C, Kremers Hilal Maradit, Vanness David J, O'Fallon W Michael, Cabanela Rosa L, Gabriel Sherine E. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health. 2003 Mar-Apr;6(2):144–157. [PubMed]
  • Towheed T, Shea B, Wells G, Hochberg M. Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev. 2000;(2):CD000517–CD000517. [PubMed]
  • Bollini P, García Rodríguez LA, Pérez Gutthann S, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med. 1992 Jun;152(6):1289–1295. [PubMed]
  • Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787–796. [PubMed]
  • Ofman Joshua J, MacLean Catherine H, Straus Walter L, Morton Sally C, Berger Marc L, Roth Elizabeth A, Shekelle Paul. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol. 2002 Apr;29(4):804–812. [PubMed]
  • Tramèr MR, Moore RA, Reynolds DJ, McQuay HJ. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain. 2000 Mar;85(1-2):169–182. [PubMed]
  • Deeks Jonathan J, Smith Lesley A, Bradley Matthew D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ. 2002 Sep 21;325(7365):619–619. [PMC free article] [PubMed]
  • Capurso L, Koch M. La prevenzione del danno gastrico da FANS: H2 antagonisti o misoprostol? Una meta-analisi degli studi clinici controllati. Clin Ter. 1991 Dec 15;139(5-6):179–189. [PubMed]
  • Leandro G, Pilotto A, Franceschi M, Bertin T, Lichino E, Di Mario F. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci. 2001 Sep;46(9):1924–1936. [PubMed]
  • Rostom A, Wells G, Tugwell P, Welch V, Dubé C, McGowan J. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials. J Rheumatol. 2000 Sep;27(9):2203–2214. [PubMed]
  • Shield MJ. Diclofenac/misoprostol: novel findings and their clinical potential. J Rheumatol Suppl. 1998 May;51:31–41. [PubMed]
  • Konstam MA, Weir MR, Reicin A, Shapiro D, Sperling RS, Barr E, Gertz BJ. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation. 2001 Nov 6;104(19):2280–2288. [PubMed]
  • Gabriel SE, Jaakkimainen RL, Bombardier C. The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events. Arthritis Rheum. 1993 Apr;36(4):447–459. [PubMed]
  • Pellissier JM, Straus WL, Watson DJ, Kong SX, Harper SE. Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis. Clin Ther. 2001 Jul;23(7):1061–1079. [PubMed]
  • de Craen AJ, Di Giulio G, Lampe-Schoenmaeckers JE, Kessels AG, Kleijnen J. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. BMJ. 1996 Aug 10;313(7053):321–325. [PMC free article] [PubMed]
  • Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, Darke AC. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol. 2000 Mar;27(3):764–771. [PubMed]
  • Emkey Ronald, Rosenthal Norman, Wu Shu-Chen, Jordan Donna, Kamin Marc. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol. 2004 Jan;31(1):150–156. [PubMed]
  • Kjaersgaard-Andersen P, Nafei A, Skov O, Madsen F, Andersen HM, Krøner K, Hvass I, Gjøderum O, Pedersen L, Branebjerg PE. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain. 1990 Dec;43(3):309–318. [PubMed]
  • Parr G, Darekar B, Fletcher A, Bulpitt CJ. Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol. 1989 Feb;27(2):235–242. [PMC free article] [PubMed]
  • McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000 Mar 15;283(11):1469–1475. [PubMed]
  • Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;(1):CD002946–CD002946. [PubMed]
  • Leeb BF, Schweitzer H, Montag K, Smolen JS. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol. 2000 Jan;27(1):205–211. [PubMed]
  • Pavelká K, Gatterová J, Gollerova V, Urbanová Z, Sedlácková M, Altman RD. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage. 2000 Sep;8(5):335–342. [PubMed]
  • Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;(1):CD002947–CD002947. [PubMed]
  • Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology (Oxford) 2001 Jul;40(7):779–793. [PubMed]
  • Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum Engl Ed. 1997 Dec;64(12):825–834. [PubMed]
  • Maheu E, Mazières B, Valat JP, Loyau G, Le Loët X, Bourgeois P, Grouin JM, Rozenberg S. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 1998 Jan;41(1):81–91. [PubMed]
  • Lequesne Michel, Maheu Emmanuel, Cadet Christian, Dreiser Renèe-Liliane. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum. 2002 Feb;47(1):50–58. [PubMed]
  • Dougados M, Nguyen M, Berdah L, Maziéres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum. 2001 Nov;44(11):2539–2547. [PubMed]
  • Fagnani F, Bouvenot G, Valat JP, Bardin T, Berdah L, Lafuma A, Bono I, Eschwege E, Dreiser RL. Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis. Pharmacoeconomics. 1998 Jan;13(1 Pt 2):135–146. [PubMed]
  • Brocq Olivier, Tran Gali, Breuil Véronique, Grisot Christian, Flory Philippe, Euller-Ziegler Liana. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine. 2002 Jun;69(4):388–391. [PubMed]
  • Vad Vijay B, Sakalkale Durgadas, Sculco Thomas P, Wickiewicz Thomas L. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil. 2003 Aug;84(8):1224–1226. [PubMed]
  • Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol. 2003 Sep-Oct;21(5):605–610. [PubMed]
  • Flanagan J, Casale FF, Thomas TL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl. 1988 May;70(3):156–157. [PMC free article] [PubMed]
  • Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis. 1997 Aug;56(8):476–480. [PMC free article] [PubMed]
  • Murphy Stephen, Deshmukh Rahul. Periacetabular osteotomy: preoperative radiographic predictors of outcome. Clin Orthop Relat Res. 2002 Dec;(405):168–174. [PubMed]
  • Takatori Y, Ninomiya S, Nakamura S, Morimoto S, Moro T, Nagai I. Long-term results of rotational acetabular osteotomy in young patients with advanced osteoarthrosis of the hip. J Orthop Sci. 2000;5(4):336–341. [PubMed]
  • Takatori Y, Ninomiya S, Nakamura S, Morimoto S, Moro T, Nagai I, Mabuchi A. Long-term results of rotational acetabular osteotomy in patients with slight narrowing of the joint space on preoperative radiographic findings. J Orthop Sci. 2001;6(2):137–140. [PubMed]
  • Yasunaga Y, Takahashi K, Ochi M, Ikuta Y, Hisatome T, Nakashiro J, Yamamoto S. Rotational acetabular osteotomy in patients forty-six years of age or older: comparison with younger patients. J Bone Joint Surg Am. 2003 Feb;85-A(2):266–272. [PubMed]
  • Hasegawa Yukiharu, Iwase Toshiki, Kitamura Shinji, Yamauchi Ki Ken-ichi, Sakano Shinji, Iwata Hisashi. Eccentric rotational acetabular osteotomy for acetabular dysplasia: follow-up of one hundred and thirty-two hips for five to ten years. J Bone Joint Surg Am. 2002 Mar;84-A(3):404–410. [PubMed]
  • Helenius I, Tanskanen P, Haapala J, Niskanen R, Remes V, Mokka R, Korkala O. Hip arthroscopy in osteoarthritis. A review of 68 patients. Ann Chir Gynaecol. 2001;90(1):28–31. [PubMed]
  • Margheritini F, Villar RN. The efficacy of arthroscopy in the treatment of hip osteoarthritis. Chir Organi Mov. 1999 Jul-Sep;84(3):257–261. [PubMed]
  • Beck Martin, Leunig Michael, Parvizi Javad, Boutier Vincent, Wyss Daniel, Ganz Reinhold. Anterior femoroacetabular impingement: part II. Midterm results of surgical treatment. Clin Orthop Relat Res. 2004 Jan;(418):67–73. [PubMed]
  • Ganz R, Gill TJ, Gautier E, Ganz K, Krügel N, Berlemann U. Surgical dislocation of the adult hip a technique with full access to the femoral head and acetabulum without the risk of avascular necrosis. J Bone Joint Surg Br. 2001 Nov;83(8):1119–1124. [PubMed]
  • Faulkner A, Kennedy LG, Baxter K, Donovan J, Wilkinson M, Bevan G. Effectiveness of hip prostheses in primary total hip replacement: a critical review of evidence and an economic model. Health Technol Assess. 1998;2(6):1–133. [PubMed]
  • Fitzpatrick R, Shortall E, Sculpher M, Murray D, Morris R, Lodge M, Dawson J, Carr A, Britton A, Briggs A. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess. 1998;2(20):1–64. [PubMed]
  • Kawasaki Masashi, Hasegawa Yukiharu, Sakano Shinji, Torii Yukio, Warashina Hideki. Quality of life after several treatments for osteoarthritis of the hip. J Orthop Sci. 2003;8(1):32–35. [PubMed]
  • Nilsdotter A-K, Petersson IF, Roos EM, Lohmander LS. Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis. 2003 Oct;62(10):923–930. [PMC free article] [PubMed]
  • Visuri T, Pulkkinen P, Turula KB, Paavolainen P, Koskenvuo M. Life expectancy after hip arthroplasty. Case-control study of 1018 cases of primary arthrosis. Acta Orthop Scand. 1994 Feb;65(1):9–11. [PubMed]
  • Dolin Simon J, Williams Amanda C de C, Ashford Nicholas, George Julie, Pereira Liz, Perello Antonio. Factors affecting medical decision-making in patients with osteoarthritis of the hip: allocation of surgical priority. Disabil Rehabil. 2003 Jul 22;25(14):771–777. [PubMed]
  • Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA. 1996 Mar 20;275(11):858–865. [PubMed]
  • O'Shea K, Bale E, Murray P. Cost analysis of primary total hip replacement. Ir Med J. 2002 Jun;95(6):177–180. [PubMed]
  • Rorabeck CH, Bourne RB, Laupacis A, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res. 1994 Jan;(298):156–164. [PubMed]
  • Maillefert Jean Francis, Gueguen Alice, Nguyen Minh, Berdah Laurent, Lequesne Michel, Mazieres Bernard, Vignon Eric, Dougados Maxime. A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol. 2002 Feb;29(2):347–352. [PubMed]
  • Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum. 1995 Nov;38(11):1535–1540. [PubMed]
  • Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002 Feb;46(2):328–346. [PubMed]
  • Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996 Aug 28;276(8):637–639. [PubMed]
  • Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000 Oct 17;133(8):635–646. [PubMed]
  • Black N. Evidence-based surgery: A passing fad? World J Surg. 1999 Aug;23(8):789–793. [PubMed]
  • Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996 May 11;312(7040):1215–1218. [PMC free article] [PubMed]

Figures and Tables

Figure 1
 Interventions for hip osteoarthritis from the general literature search. SYSADOA, symptomatic slow acting drugs for OA; THR, total hip replacement.
Figure 2
 Study designs for hip OA from the general literature search. EE, economic evaluation; SR, systematic review; RCT, randomised controlled trial; CT, controlled trial.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...